hepatitis C

Racing Toward the Next Hepatitis C Drug Approval

Racing Toward the Next Hepatitis C Drug Approval

Motley Fool

[video]FDA Prioritizes New Hepatitis C Drug

[video]FDA Prioritizes New Hepatitis C Drug

Motley Fool

Gilead's Hepatitis C Drug Sofosbuvir Offers Upside

Gilead's Hepatitis C Drug Sofosbuvir Offers Upside

Seeking Alpha

FDA ‘breakthrough’ tab on AbbVie Hepatitis C drug leaves shares flat

FDA ‘breakthrough’ tab on AbbVie Hepatitis C drug leaves shares flat

Marketwatch

Gilead's HCV Drug Pipeline Outshines Weak Q1 Results

Gilead's HCV Drug Pipeline Outshines Weak Q1 Results

Investors.com

Gilead combo hepatitis C pill shown effective in small trial

Gilead combo hepatitis C pill shown effective in small trial

Reuters

Gilead-Bristol Hepatitis C Drug Combo Cures All in Study

Gilead-Bristol Hepatitis C Drug Combo Cures All in Study

Bloomberg

Gilead-Bristol Hepatitis C Drug Combo Cures 100% in Study

Gilead-Bristol Hepatitis C Drug Combo Cures 100% in Study

Bloomberg

Bristol Still Playing Catch-Up To Gilead In Hep C Drug Race

Bristol Still Playing Catch-Up To Gilead In Hep C Drug Race

TheStreet.com

Gilead announces results from Phase 3 trial evaluating sofosbuvir

Gilead announces results from Phase 3 trial evaluating sofosbuvir

Yahoo/Fly on the Wall